RE: Hello28 May 2020 15:36
The market will always judge the sp in regards to the risk/reward ratio
The more we progress in the regulatory process the more we reduce the risk factor
The next milestones for the SP
Successful results in the P2 trials
Pharma partnership/ licensing agreement
For P3's
Until then , all we can do is hope and pray..
Eyes to the sky but feet on the ground :-)
Hope for the best but be prepared for the worst , is always my advice .....